A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen
Crossref DOI link: https://doi.org/10.1186/s12885-017-3210-z
Published Online: 2017-03-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lereclus, Emilie
Tout, Mira
Girault, Alban
Baroukh, Nadine
Caulet, Morgane
Borg, Christophe
Bouché, Olivier
Ternant, David
Paintaud, Gilles
Lecomte, Thierry
Raoul, William
Funding for this research was provided by:
SNFGE (FARE SNFGE 2013-2014)
Fondation de France (2015-2017)
